PRESS RELEASE

Aug 06, 2026
BioStem Technologies Announces Nasdaq Uplisting
Read More
Jul 29, 2026
BioStem Technologies to Host Second Quarter 2026 Financial Results Conference Call on August 12, 2026
Read More
Jul 10, 2026
BioStem Technologies Publicly Files Form 10 Registration Statement with the Securities and Exchange Commission
Read More
Jul 08, 2026
BioStem Technologies Announces Issuance of Four U.S. Design Patents Covering Fenestrated Human Placental Allograft Technologies
Read More
Jun 10, 2026
BioStem Technologies to Present at the Planet MicroCap Las Vegas 2026 Conference
Read More
Jun 09, 2026
BioStem Technologies Announces Appointment of Three New Members to its Board of Directors
Read More
May 22, 2026
BioStem Technologies Announces $2.5 Million Private Placement Financing with its First Institutional Investor
Read More
May 20, 2026
BioStem Technologies Announces Notice of Allowance for Four U.S. Design Patent Applications Covering Fenestrated Human Placental Allografts and One European Patent
Read More
May 14, 2026
BioStem Technologies Reports First Quarter 2026 Financial Results
Read More
May 12, 2026
BioStem Technologies to Present at the 16th Annual LD Micro Invitational
Read More
Load more news